Sacheerome Q1 FY27 Share Price & Earnings Call Analysis

₹425.35+9.80% today
Market cap
₹951 Cr
P/E
33.55
ROE
26.96%
PEG
0.49
Price to sales
6.24
Debt to equity
0.00
52W high / low
₹537 / ₹213
EBITDA margin
24.12%
Net profit margin
18.60%
Promoter holding
71.54%
Sales (last year)
₹152 Cr

Incorporated in 2009, Sacheerome Ltd is in the business of designing & manufacturing fragrance and flavours[1]

Guidance scorecard · Q1 FY27 call

What Sacheerome Ltd's management guided
and where it ranks in Chemicals & Petrochemicals

#29of 71 in
Chemicals & Petrochemicals

RevenueQ4 FY26 call

20–40%
  • Sacheerome Limited expects gradual revenue growth driven by increasing market demand, customer additions, product mix refinement, and export expansion.
  • The upcoming manufacturing facility at YEIDA, with a significant capacity expansion (approx. 4x increase), is expected to support future growth starting August 2026.
  • Management provided conservative guidance for doubling revenue from around INR152 crores in FY26 to INR300 crores by FY29, emphasizing gradual ramp-up of capacity utilization.
  • There is confidence in demand growth from both domestic FMCG players and global customers, with many products in the development and approval pipeline.
  • They foresee increased market share in both fragrance and flavor segments, with flavors expected to grow rapidly supported by a dedicated facility.

2 more points from Sacheerome Ltd's call on revenue

Create a free account to keep reading this call

Full Q4 FY26 analysis

MarginsQ4 FY26 call

Flat

See what Sacheerome Ltd said on margins — free account, 30 seconds.

Full Q4 FY26 analysis

CapexQ4 FY26 call

Planned
  • Sacheerome Limited is undertaking a major manufacturing expansion with a new facility at Yamuna Expressway Industrial Development Area (YEIDA).
  • Total capex for this new facility is approximately INR 184 crores.
  • As of March 31, 2026, around INR 76.59 crores have been invested in YEIDA facility—INR 28.79 crores from IPO funds and INR 47.80 crores from internal accruals.
  • The YEIDA facility is expected to commence commercial operations by August 2026.
  • This investment aims to multiply production capacity by 4 times, improve automation, manufacturing efficiency, product consistency, and export capabilities.
  • Additional debt of around INR 60 crores may be taken as required to complete the facility.

2 more points from Sacheerome Ltd's call on capex

Create a free account to keep reading this call

Full Q4 FY26 analysis

FundraisingQ4 FY26 call

See what Sacheerome Ltd said on fundraising — free account, 30 seconds.

Full Q4 FY26 analysis

Order bookQ4 FY26 call

  • The company mentions having a strong demand pipeline with many products in development and commercial launch stages.
  • Manoj Arora highlights that they are operating at overcapacity (around 124% utilization) and expanding capacity to meet growing demand.
  • There is mention of multiple development projects, product approvals, and commercial launches in both fragrances and flavors.
  • The company expects to ramp up production gradually as the new facility (capex INR184 crores) becomes operational.

2 more points from Sacheerome Ltd's call on the order book

Create a free account to keep reading this call

Full Q4 FY26 analysis

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. 2
  2. Strong growth
    1
  3. Strong growth
    3

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹263 Cr3.4
240%+Flat₹4,375 Cr83.7
340%+Flat₹3,259 Cr4.0
440%+Flat₹145 Cr15.9
520–40%Up 2%+₹1.81L Cr90.9
620–40%Up 2%+₹48,366 Cr78.3

Sacheerome Ltd announcements

All announcements →

Financials of Sacheerome Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Sacheerome Ltd

Quarterly Results

Quarter-by-quarter operating performance

No quarterly results data available for this company yet.

Financials of Sacheerome Ltd

Profit & Loss

Annual income statement trend

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +647085108152
Expenses +55617085116
Operating Profit910152337
OPM %13%14%18%21%24%
Other Income +00114
Interest11000
Depreciation22222
Profit before tax68152138
Tax %27%28%27%25%25%
Net Profit +56111628
EPS in Rs11.1414.676.509.7812.71
Dividend Payout %0%0%0%0%0%

Financials of Sacheerome Ltd

Balance Sheet

Capital structure and asset base

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital44161622
Reserves25313046126
Borrowings +80130
Other Liabilities +1114161924
Total Liabilities49496485172
Fixed Assets +921222323
CWIP0282857
Investments00001
Other Assets +4027333490
Total Assets49496485172

Financials of Sacheerome Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +9111022
Cash from Investing Activity +-4-2-10-23
Cash from Financing Activity +-6-912
Net Cash Flow-1011
Free Cash Flow690-2
CFO/OP141%128%91%124%

Financials of Sacheerome Ltd

Ratios

Working capital efficiency and return ratios

Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days6763685247
Inventory Days113100856347
Days Payable7173738061
Cash Conversion Cycle10989803534
Working Capital Days3763582431
ROCE %24%36%39%36%

Guidance history

How Sacheerome Ltd's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q4 FY26 call →20–40%FlatPlanned——
Q2 FY26 call →20–40%FlatPlannedPlannedRising

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

41out of 100

Momentum score · price trend

41 out of 100 — Steady

Over the past year its share price has moved roughly in the middle of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months+89.6%93%
Last 6 months+27.9%79%
Last 3 months+2.0%67%

The price is 20.8% below its all-time high of ₹536.85 (18 Sept 2026). Stocks more than 20% below their peak have their score halved, so 82 became 41.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Sacheerome Ltd: 0.4 × 93 + 0.4 × 79 + 0.2 × 67 = 82, halved to 41 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 29 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Others in Chemicals & Petrochemicals this season

  • POCL Enterprises Ltd (Q1 FY27)

    466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto

  • Deepak Nitrite Ltd (Q2 FY27)

    Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese

  • Privi Speciality Chemicals Ltd (Q2 FY27)

    19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks

  • NOCIL Ltd (Q2 FY27)

    427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.